Abstract We have previously shown that transduction of HOXD3, one of homeobox genes, into human lung cancer A549 cells enhances cell motility, invasion and metastasis. In the present study, we examined the roles of integrin b3 which was up-regulated by HOXD3-overexpression in the HOXD3-induced motility of A549 cells. We first established integrin b3-transfectants and compared their motile activity to those of the HOXD3-transfected, control-transfected and parental cells by three different assays. The integrin b3-transfectants as well as the HOXD3-transfectants formed heterodimer with integrin av subunit, and showed highly motile activities assessed by haptotaxis or phagokinetic track assay compared to the control transfectants or parental cells. In vitro wound-healing assay revealed that migratory activities were graded as the HOXD3-transfectants > the integrin b3-transfectants > the control transfectants or parental cells. E-cadherin was expressed in the integrin b3-transfectants but not expressed in the HOXD3-transfectants. An addition of function-blocking antibody to E-cadherin into the wound-healing assay promoted the migratory activity of the integrin b3-transfectants,
Introduction
The metastatic process is a series of sequential steps in which tumor cells are released from the primary tumor and disseminated to distant sites, where they proliferate to form new tumor foci [1, 2] . Dynamic cell movement observed in tumor metastasis is similar to that observed during embryonic morphogenesis, although there is a difference that tumor cells move, destroying normal tissues, whereas normal cells move, maintaining homeostasis in morphogenesis. We hypothesized therefore that metastatic tumor cells might undergo at least a part of the genetic program of embryonic morphogenesis.
Homeobox-containing genes are well known as master control genes in development [3] . One family of human homeobox-containing genes is HOX whose prototype is HOM in Drosophila [4] . Thirty-nine HOX genes are clustered in a similar arrangement of 13 paralog groups on four different chromosomal/ genomic regions, HOXA, B, C, and D and encode transcription factors [4] [5] [6] [7] . They are expressed in a spatio-temporal manner during embryonic morphogenesis, each regulating a group of genes involved in modeling a specific segmental architecture. Their expression has also been detected in normal adult tissues with characteristic patterns, suggesting their possible role in the maintenance of normal tissue homeostasis [8, 9] .
HOX gene products control the expression of a set of morphogenesis-associated genes, one of which is cell adhesion molecules. Accumulated evidence indicates that several adhesion molecules are target genes for HOX gene products. For example, experiments by cotransfection into NIH3T3 cells indicate that Xenopus HoxC6, HoxB9 and HoxB8 modulate promoter activity of mouse neural cell adhesion molecule (N-CAM) [10, 11] . Human melanoma cells whose HOX C locus genes are silent show high levels of integrin a2b1, a5b1, a6b1 and intercellular cell adhesion molecule (ICAM) whereas those whose HOX C locus genes are actively expressed show low levels of ICAM-1 and lack a2b1, a5b1, a6b1 [12] . Ectopic expression of HOXA7 induces E-cadherin expression in immortalized ovarian surface epithelial cells [13] . We have provided evidence that transduction of HOXD3 gene into human erythroleukemia HEL cells leads expression of integrin b3 which forms heterodimer with aIIb [14] . Boudreau et al. also have observed that integrin b3 is one of the target genes for HOXD3 in their experiment using human endothelial cells [15] . Further, our previous study has shown that human lung cancer A549 cells overexpressing HOXD3 gene enhance the expressions of Ncadherin and integrins such as a3, a4 and b3 subunits, and eliminate E-cadherin expression [16] . It is reasonable that some HOX genes regulate directly or indirectly the expressions of cell adhesion molecules because the molecules play an important role in cellcell and cell-matrix recognition which leads cell proliferation, migration, differentiation and death in morphogenesis. Thus, the aberrant expression of HOX genes in tumor cells is thought to induce the invasive and metastatic phenotype through the altered expression of cell adhesion molecules.
In the present study, we report that integrin b3, which is up-regulated by HOXD3-overexpression, functioned as a major motility-promoting molecule and that loss of E-cadherin expression by HOXD3-overexpression may facilitate cell scattering.
Materials and methods

Antibodies and reagents
A mouse monoclonal antibody to integrin b3 (RUU-PL7F12) was purchased from Becton Dickinson (San Jose, CA). Mouse monoclonal antibodies to integrin b1 (P5D2), integrin a4 (P4C2), integrin avb3 (LM609), integrin avb5 (P1F6), integrin avb6 (E7P6) and normal mouse IgG were from Chemicon International (Temecula, CA). LM609 recognizes avb3 heterodimer and inhibits adhesion of cells to vitronectin through avb3 [17] . A mouse monoclonal antibody to E-cadherin (clone 36) for immunoblotting was from Transduction Laboratories (Lexington, KY). A mouse monoclonal antibody to E-cadherin (HECD-1) for blocking E-cadherin dependent cell-cell contact was from Takara Shuzo (Ohtsu, Japan). A fluorescein-5-isothiocyanate-conjugated goat polyclonal antibody to mouse IgG was from Cappel (Aurora, OH). A peroxidase-conjugated sheep polyclonal antibody to mouse Ig was from Amersham (Little Chalfont, England). Bovine plasma vitronectin was from Yagai (Yamagata, Japan). Bovine plasma fibronectin, mouse laminin-1, Lipofectamine PLUS and TRIzol were from Gibco BRL (Grand island, NY). Human fibrinogen was from Sigma (St. Louis, MO). Bovine serum albumin was from Boehringer Mannheim (Mannheim, Germany). Hygromycin B was from Wako (Tokyo, Japan). G418 sulfate was from Cellgro (Herndon, VA). The Transwell chamber and culture dishes were from Costar (Cambridge, MA). Tissue culture plates and dishes were from Becton Dickinson (Lincoln Park, NJ).
Cells and cell culture
Human lung cancer A549 cells were obtained from the Japanese Cancer Research Resources Bank (JCRB, Tokyo, Japan). The cells were grown on tissue culture dishes in a 1:1 (v/v) mixture of Dulbecco's-modified Eagle's minimum essential medium and Ham's F12 medium (DME/F12) supplemented with 5% of heatinactivated fetal bovine serum (FBS). HOX+1 and HOX+2 were HOXD3-overexpressing clones isolated from the parental cells which had been transfecetd with the HOXD3 expression vector pMAMneo-HOX4A. Neo1 and Neo2 were control clones isolated from the parental cells which had been transfected with only pMAMneo vector. The HOX+1, HOX+2, Neo1 and Neo2 cells were grown in DME/F12 containing 5% FBS and 400 lg/ml of G418 sulfate. All cell lines were cultured in a CO 2 incubator (5% CO 2 and 95% air).
Construction of plasmids
Full-length cDNA encoding the human integrin b3 subunit was kindly provided by Dr. David A. Cheresh (The Scripps Research Institute, La Jolla, CA) [18] . From this cDNA, the region of integrin b3 containing translation-starting codon to stop codon was amplified by PCR with the use of the forward primer 5¢-CGGGAGGCGGACGAGATGCGAGC-3¢ and the reverse primer 5¢-GCCCCGAAATCCCTCCC-CACAAATACTG-3¢. The PCR product was subcloned into the multi-cloning site of the pTARGET (pTARGET-Int b3) (Promega. Madison, WI). The pTARGET-Int b3 was digested with XhoI and SalI and subcloned into the multi-cloning site of pcDNA3.1Hyg(+) (Invitrogen) which had been digested with XhoI (pcDNAHyg(+)-Intb3).
Transfection and cell cloning
The transfection of pcDNA3.1Hyg(+)-Int b3 or pcDNA3.1Hyg(+) into Neo1 cells was performed with Lipofectamine PLUS according to the manufacturer's instruction. The cells stably transfected with the pcDNA3.1Hyg(+)-Int b3 or pcDNA3.1Hyg(+) were selected by their resistance to both 400 lg/ml of G418 sulfate and 100 U/ml of hygromycin B. G418 sulfateand hygromycin B-resistant cells which had been transfected with the pcDNA3.1Hyg(+)-Int b3 were expanded, and the cells expressing integrin b3 on their cell surface were enriched by magnetic cell sorting using MACS goat anti-mouse IgG microbeads system (Miltenyi Biotec, Bergisch Gladbach, Germany) and the integrin b3-specific antibody RUU-PL7F12. After the magnetic cell sorting, the cells were cloned by the limiting dilution method. The integrin b3 expression of the cloned cells was analyzed by flow cytometry using RUU-PL7F12 monoclonal antibody. We isolated three clones which expressed integrin b3 at the similar level to those in HOX+1 and HOX+2 cells and designated them Neo1 b3-1, Neo1 b3-2, Neo1 b3-3. Neo1Hyg1 and Neo1Hyg2 were cloned from G418 sulfate-and hygromycin B-resistant cells which had been transfected with pcDNA3.1Hyg(+). The Neo1 b3-1, Neo1 b3-2, Neo1 b3-3, Neo1Hyg1 and Neo1Hyg2 cells were grown in DME/F12 containing 5% FBS and 400 lg/ml of G418 sulfate and 100 U/ml hygromycin B.
Semiquantitative duplex RT-PCR analysis
For RT-PCR analysis, total RNA was extracted from monolayer cultures of each cell line with Trizol according to the manufacturer's instruction. Three lg of total RNA sample was subjected to cDNA synthesis for 2 h at 37°C in 50 ll of reaction mixture containing 4 U/ll of Molony murine leukemia virus reverse transcriptase, 10 mM dithiothreitol, 0.5 mM MgCl 2 , 0.5 lM dNTP and 2 lM random primer. PCR amplification of cDNA was performed in 50 ll of reaction mixture containing 1 ll of cDNA sample, 10 mM TrisHCl (pH 8.3), 50 mM KCl, 2 mM MgCl 2 , 0.125 U/ll of Taq polymerase and different primer sets (10 nM each). Co-amplification of the specific gene and human b-actin gene, as an internal control, was achieved by using two primer sets in a single reaction mixture. Each primer was designed to encompass an exon junction for prevention of templating possibly contaminated genomic DNA. The sense/antisense primers for PCR were designed as follows: (a) HOXD3 (434 bp), 5¢-AGGA-TCCTGGTCTGAAACTCAGAGC-3¢/5¢-ACTCGAG TTCATCCGCCGGTTCTGGAACCA-3¢; (b) integrin b3 (526 bp), 5¢-CTCCATCCAAGTGCGGCAGG TGGAG-3¢/5¢-CATGACACTGCCCGTCATTAGGC TGGAC-3¢; b-actin (236 bp/530 bp), 5¢-ACCTCATG-AAGATCCTCACCGAGCG-3¢ or 5¢-TCTACAAT-GAGCTGCGTGTGGCTCC-3¢/5¢-AGGAAGGAAGG CTGGAAGAGTGCCTC-3¢. PCR products were electrophoresed in a 2.5% agarose gel and intensity of the bands was observed under a UV illuminator.
Flow cytometry
The cultured cells were harvested by trypsinization and washed twice with PBS containing 0.065% sodium azide. The cells were incubated with primary antibodies for 1 h at 4°C, and then with secondary antibodies conjugated with FITC. After incubation, the cells were washed three times with PBS containing 0.065% sodium azide. The stained cells were resuspended in 1 ml of PBS containing 0.065% sodium azide and analyzed with the use of FACSCalibur (Becton Dickinson, San Jose, CA).
Haptotaxis assay
Haptotaxis assay was performed by using Transwell chambers by the same method described in our previous report [16] . The lower surface of the membranes with 8-lm pores of Transwell chambers was coated with 10 lg each of vitronectin, fibronectin, fibrinogen or laminin-1. Six hundreds ll of DME/F12 containing 0.1% BSA was placed into the lower compartment of the Transwell chambers, and then 100 ll of the cell suspension (2 · 10 5 cells/ml in DME/F12 containing 0.1% BSA) was placed into the upper compartment. After 6-h incubation, each membrane was fixed with 10% neutral-buffered formalin and stained in Giemsa solution. After the cells attached to the upper side of the membrane were removed by wiping with a cotton swab, those attached to the lower side of the membrane were counted under a microscope. Haptotactic activity was evaluated by the number of cells per field at 200· magnification (mean ± SD, n = 20).
Phagokinetic track assay
Phagokinetic track assay was performed to assess the random cell motility by the same method described in our previous report [16] . Briefly, the gold particlecoated coverglasses were placed in 35-mm tissue culture dishes, and 2,000 tumor cells suspended in DME/ F12 supplemented with 1% FBS were added into each dish. After 24-h incubation, the coverglasses were fixed for 30 min in 10% neutral-buffered formalin and mounted on slide glasses by using Gelmount (Biomeda, Foster City, CA). The phagokinetic tracks were observed with Nikon microscope. The area cleared of gold particles by randomly selected 20 cells was measured with an apparatus for image analysis (Nikon Cosmozone R500) connected to the microscope at a magnification of 200·.
In vitro wound-healing assay
In vitro wound-healing assay for measuring cell migrating activity was carried out by the method reported by Boyer et al. [19] . Briefly, confluent cell monolayers were obtained after 48 h of culture in DME/F12 supplemented with 5% FBS. They were gently scratched with a Gilson pipette yellow tip, and extensively rinsed with DME/F12 medium to remove all cellular debris. This procedure left a cell-free area of substratum (''wound''). Then, the cultures were allowed to grow in DME/F12 supplemented with 1% FBS. After making ''wound'', the cultures were observed with a phase-contrast inverted microscope and photographed.
For determining the roles of E-cadherin in the in vitro wound healing, the cells were seeded on Chamber Slide with 8 chambers (Nalge Nunc, Naperville, IL). At confluent point of the cell monolayers, DME/F12 containing 5% FBS was replaced with PBS containing 2 mM MgCl 2 and 2 lM CaCl 2 . After 2-h incubation, the PBS was replaced with DME/F12 supplemented with 1% FBS, and simultaneously 100 lg/ml of anti-Ecadherin antibody or normal mouse IgG was added. Immediately after the addition of antibodies, the monolayers were scratched for the assay.
Immunoblot analysis
Tumor cells (2 · 10 6 /dish) were seeded on 100-mm tissue culture dish in DME/F12 supplemented with 5% FBS. After 24-h incubation, the cells were washed twice with 10 ml of cold PBS, and then harvested with a cell scraper in lysis buffer (20 mM Hepes, pH 7.6, 150 mM NaCl, 1 mM EDTA, 50 mM NaF, 1% Triton X-100, 1 mM Na 3 VO 4 , 5 lg/ml Pepstatin A, 5 lg/ml Leupeptin). The cell lysates were centrifuged at 20,000g for 10 min at 4°C. The supernatants were collected and protein concentration was determined by modified Bradford assay (Bio-Rad protein assay, Bio-Rad, Hercules, CA). Equal amounts of protein were separated by SDS-PAGE in 7.5% polyacrylamide gel and electrotransferred to Immobilon membranes (Millipore, Bedford, MA). The membranes were blocked in TBS-T (20 mM Tris-HCl, pH 7.5, 137 mM NaCl, 0.1% Tween 20) with 5% skim milk overnight at 4°C, and then incubated with primary antibodies for 1 h at room temperature. The membranes were incubated next with horseradish peroxidase-conjugated antibodies for 1 h at room temperature, and developed by the Enhanced Chemiluminescent Detection System (Amersham Pharmacia, Little Chalfont, UK).
Results
Expressions of HOXD3 and integrins in integrin b3-overexpressing A549 cells
First we examined expression of HOXD3 gene and integrin b3 gene in the cell lines used in this study by RT-PCR analysis. It was confirmed that the cloned transfectants with HOXD3 gene (HOX+1 and HOX+2) expressed both HOXD3 and integrin b3; those with integrin b3 gene (Neo1 b3-1, Neo1 b3-2 and Neo1 b3-3) did only integrin b3; parental and the control transfectants (Neo1 and Neo1Hyg1 and Neo1Hyg2) did neither of them (Fig. 1A, B) . Cell surface expressions of integrins were analyzed by flow cytometry using antibodies to integrins b3, avb3, avb5, avb6, a4 and b1. The integrin b3-overexpressing cells as well as the HOXD3-overexpressing cells showed the formation of avb3 heterodimer (Fig. 2) . The expression of integrin avb5 tended to decrease in the HOXD3-and the integrin b3-overexpressing cells compared to the control cells (Fig. 2) . No cell lines showed the expression of integrin avb6 (data not shown). The control cells showed no expression of integrin a4 subunit whereas the HOXD3-overexpressing and the integrin b3-overexpressing cells newly showed the expression of integrin a4 (although the expression levels of integrin a4 in the integrin b3-overexpressing clones were fairly low) (Fig. 2) . The integrin b1 expression was not affected by the integrin b3 transduction (Fig. 2) .
Haptotactic activity of the integrin b3-overexpressing A549 cells
As the HOXD3-overexpressing A549 cells increased their haptotactic activities to vitronectin, fibrinogen and fibronectin [16] , we examined the haptotactic activities of the integrin b3-overexpressing cells. Haptotactic activities of the integrin b3-overexpressing cells as well as the HOXD3-overexpressing cells to vitronectin and fibrinogen, which are of ligands highly specific to avb3, were significantly higher than those of the parental and the control transfectant cells (Fig. 3A,  B) . The haptotactic activity of the integrin b3-overexpressing cells to fibronectin, which is a ligand for avb3, was significantly lower than that of the HOXD3-overexpressing cells although significantly higher than that of the parental and the control transfectant cells (Fig. 3C) . However, no significant difference was observed in haptotactic activity to laminin which is not a ligand for avb3 among all cell lines tested (Fig. 3D) .
Phagokinetic activity of the integrin b3-overexpressing A549 cells Unlike haptotaxis assay, phagokinetic track assay was performed in the absence of specific attractants for cell migration such as extracellular matrix components. And thus cell motility assessed by phagokinetic track assay shows non-directed motility, so-called random motility. As shown in Fig. 4A and B, the integrin Fig. 1 Expressions of HOXD3 and integrin b3 in parental A549 cells and the cells transfected with either HOXD3 or integrin b3 gene. Total RNA was extracted from the cultured cells; after reverse transcription, a duplex polymerase chain reaction (PCR) was performed with the primers for HOXD3 or integrin b3 and for b-actin. After the PCR amplification, the samples were electrophoresed and stained with ethidium bromide. HaeIIIdigested /X174 DNA was used as size markers b3-overexpressing cells, as well as the HOXD3-overexpressing cells, showed high motile activities compared to the parental and the control transfectants. There was no difference in cell motility between the integrin b3-overexpressing cells and the HOXD3-overexpressing cells. An addition of the blocking antibody to integrin avb3 (LM609) into the assay reduced the phagokinetic activities of both HOXD3-or integrin b3-overexpressing cells to the level of the control transfectants (Fig. 4C) .
In vitro wound-healing activity of the integrin b3-overexpressing A549 cells Both haptotaxis and phagokinetic track assays started in the condition without cell-cell adhesion whereas in vitro wound-healing assay proceeded in the condition with cell-cell adhesion. A confluent monolayer was scratched with a micropipette tip, which left a cellfree area of substratum (''wound''). Cells on the wound edges migrated toward the wound. Cell migration distances were chronologically measured with a micrometer. Both the integrin b3-overexpressing cells and the HOXD3-overexpressing cells migrated faster than the parental and the control transfectants (Fig. 5A ). In the earlier stage after starting the assay, the migratory distance of the integrin b3-overexpressing cells was significantly shorter than that of the HOXD3-overexpressing cells (Fig. 5A, B) .
Roles of E-cadherin in in vitro wound-healing activity
In the wound-healing assay, we observed that migratory activity of the integrin b3-overexpressing cells was low in the early stage of the assay compared to that of the HOXD3-overexpressing cells. We earlier reported that the HOXD3-overexpression led the loss of E-cadherin expression in A549 cells [16] . In vitro experiments on cultured cells indicate E-cadherin has invasion-suppressing properties [20] [21] [22] . Therefore, we next examined the expression and function of E-cadherin in the integrin b3-overexpressing cells. Immunoblot analysis revealed that the integrin b3-overexpressing cells retained the expression of E-cadherin although the HOXD3-overexpressing cells lost it (Fig. 6A ). To investigate whether the E-cadherin suppresses the cell migration from the wound edges, we added an antibody to human E-cadherin (HECD) which blocks the cell-cell contact through E-cadherins to the wound healing assay. As shown in Fig. 6B , the migratory activity of the integrin b3-overexpressing cells treated with HECD-1 antibody significantly increased compared to the non-treated cells, but the increase was not as high as that of the HOXD3-overexpressing cells.
Discussion
We have previously shown that HOXD3-overexpression enhances cell motility and increases expression of adhesion molecules such as integrin b3, a3 and a4 in human lung cancer A549 cells [16] . Following that, we focused on the roles of integrin b3 in the enhanced cell motility of the HOXD3-overexpressing cells in the present study. We first established cell clones transfected with integrin b3, and then compared their cell motile behavior to those of the HOXD3-overexpressing clones and the control clones (neomycin-or neomycin/hygromycin-resistant clones). Our present study demonstrated that integrin b3 transduced into A549 Neo1 cells formed heterodimer with integrin av subunit. The transduction of HOXD3 or integrin b3 decreased the expression of integrin avb5. The parent and transfectants analyzed here showed no expression of integrin avb6 on their cell surface (unpublished data). Further our previous report documented that HOXD3-overexpression did not have any effect on the expression of endogenous av subunit [16] . Taken together, we speculate that the av subunit dimerizing with b3 subunit is, at least partially, derived from av subunit of endogenous integrin avb5 although we further need to examine the expression of integrin avb1 and avb8.
We think that mainly the integrin avb3 was responsible for the enhanced motility by HOXD3-or b3-overexpression although we have to consider that the decreased expression of integrin avb5 may have caused the enhanced motility. As expected, integrin b3-transfectants as well as HOXD3-transfectants showed highly haptotactic activities to vitronectin and fibrinogen which were ligands specific for integrin avb3, compared to the control transfectants. Haptotaxis of integrin b3-transfectants to fibronectin was higher than that of the control transfectants and lower than the HOXD3-transfectants. Fibronectin is a ligand for a variety of integrins such as a3b1, a4b1, a5b1 and avb3 [23] . The HOXD3-transfectants expressed a3b1, a4b1 and avb3 at higher levels than the control transfectants. The integrin b3-transfectants expressed a3b1 and avb3 at the same levels as the HOXD3-transfectants; however, the expression of a4b1 slightly increased by the integrin b3-transduction. The difference in the haptotactic activity to fibronectin between the HOXD3-and integrin b 3-transfectants may result from the different levels of a2b1 expression.
It was unexpected that the avb3 expression gave A549 cells higher motility when assessed by phagokinetic track assay. This assay is often used to measure random motility, namely, motility without direction [24, 25] . In this study, the cells were seeded on coverglasses coated with BSA and gold particles in DME/ F12 containing 1% FBS. It should be noted that avb3 binds to a ligand(s) to transduce outside-in signal for motility. The ligands for avb3 in FBS are bovine fibronectin and vitronectin [23, 26] . We added fibronectin or vitronectin at almost comparable concentrations to those in 1% FBS into the FBS-free assay medium; however, neither of them could stimulate phagokinetic motility of the integrin b3-or HOXD3-transfectants (unpublished data). It is well known that FBS contains several potent motility-stimulating factors, some of which are lysophosphatidic acid (LPA), insulin, epidermal growth factor (EGF), insulin-like growth factor-I (IGF-I), platelet-derived growth factor (PDGF), and hepatocyte growth factor (HGF) [27] . LPA, EGF and HGF are unlikely to be a motility-stimulating factor for A549 cells because we have evidence that these molecules do not stimulate the phagokinetic motility of any of the transfectants used here (unpublished data). Of the above-mentioned motility-stimulating factors, receptors of insulin and PDGF associate with integrin avb3 and potentiate the biological activity of their ligands [28] [29] [30] . Therefore, it is possible that the receptors activated by insulin or PDGF which are present in the FBS form a complex with avb3, which acts on phagokinetic motility. We need further study to clarify the association of avb3 with these growth factor receptors in the cell motility enhanced by integrin b3-or HOXD3-transduction.
In vitro wound-healing assay revealed that the integrin b3-transfectants migrated faster than the control transfectants and slower than the HOXD3-transfectants. This wound-healing assay was started in the condition maintaining cell-cell contact unlike the haptotactic or phagokinetic track assay in which measures cell motility was measured in the condition where the cells were apart from each other. We showed here that HOXD3-transduction led to the loss of E-cadherin expression whereas integrin b3-transduction did not affect the E-cadherin expression. Dysfunction of the E-cadherin-mediated cell adhesion system plays an important role in acquisition of more malignant phenotype by tumor cells [31] . Experimental biological approaches also show that E-cadherin functions as an invasion-suppressor [20] [21] [22] . In the present study, the addition of function-blocking antibody to E-cadherin into the assay increased migratory activity of the integrin b3-transfectants, suggesting that E-cadherin plays a role in preventing the tumor cells from migrating from wound edge. However, the treatment with anti-E-cadherin antibody could not recover the migratory activity of the integrin b3-transfectants to the level of that of the HOXD3-transfectants. The HOXD3-transfectants are thought to operate additional system(s) to accelerate or brake the migration, although we need further investigation to demonstrate it. The anti-E-cadherin antibody treatment did not accelerate the migration of the control transfectants. We assume that disruption of cell-cell contact through the E-cadherins no longer affected the migration of the control transfectants since they were intrinsically less motile. Taken together, it is most likely that the increased expression of integrin avb3 and loss of expression of E-cadherin strongly contributed to the enhancement of various types of cell motility and dissociation in the HOXD3-overexpressing A549 cells.
As previously shown, HOXD3-overexpressing A549 cells convert latent TGF-beta into active one, which activates the TGF-b-signaling in an autocrine manner [32] . The stimulation with TGF-b enhances haptotaxis of A549 cells to type I collagen but not to vitronectin, fibrinogen or fibronectin [32] . Thus we suppose that HOXD3 enhances cell motility through the TGFb-dependent and -independent pathways in A549 cells. Further, TGF-b did not affect the expression of integrin b3 in either A549 parental cells or the control transfectants, and TGF-b-stimulated haptotaxis to type I collagen was not prevented by anti-avb3 antibody (unpublished data). Therefore, in the present study, we found that the TGF-b-independent pathway which enhanced cell motility was the integrin avb3-dependent one. It is noteworthy that one molecule (HOXD3) controls the two distinct pathways to stimulate the different types of cell motility.
Taken together with our previous study indicating that HOXD3 directly or indirectly regulates transcriptions of metastasis-related genes such as matrix metalloproteinase-2, urokinase-type plasminogen activator, E-cadherin, desmoglein and others [16, 32] , HOXD3 can be a master gene of metastasis in A549 cells. Namely, HOXD3 commands a number of soldiers which are engaged in metastasis. HOXD3 is possibly a good target in prevention and treatment of invasion and metastasis.
